VIH History Timeline and Biographies | History Timeline Generator

1981

First Cases of AIDS Reported

In June 1981, the Centers for Disease Control and Prevention (CDC) reported a cluster of rare pneumonia cases among gay men in Los Angeles, marking the first recognition of AIDS, caused by VIH. This alerted the medical community to the emerging epidemic.

1983

Discovery of VIH

In 1983, researchers at the Pasteur Institute in France identified the virus responsible for AIDS, naming it LAV (Lymphadenopathy-Associated Virus), later known as VIH. This discovery was pivotal in understanding the disease's mechanism.

1985

First Blood Test for VIH Developed

The first blood test to detect VIH antibodies was approved in 1985, allowing for widespread screening and contributing to better understanding and management of the virus in affected populations.

1987

Introduction of AZT as Treatment for VIH

In 1987, zidovudine (AZT) became the first drug approved for treating VIH. This marked a significant advancement in the fight against AIDS, offering hope to those diagnosed with the virus.

1991

Formation of the Global Fund for VIH/AIDS Research

In 1991, the Global Fund was established to combat VIH/AIDS through research and funding initiatives, significantly enhancing global efforts to control the epidemic and support affected communities.

1996

Introduction of Highly Active Antiretroviral Therapy (HAART)

The introduction of HAART in 1996 revolutionized VIH treatment, significantly reducing mortality rates and transforming HIV from a fatal diagnosis to a manageable chronic condition for many patients.

2003

Launch of PEPFAR Initiative

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was launched in 2003, providing substantial funding and resources to combat VIH/AIDS globally, particularly in sub-Saharan Africa.

2012

Introduction of Pre-Exposure Prophylaxis (PrEP)

In 2012, the FDA approved PrEP, a preventive treatment for individuals at high risk of contracting VIH, marking a significant advancement in HIV prevention strategies and public health initiatives.

2014

Global Goals to End AIDS by 2030 Established

In 2014, the United Nations set ambitious goals to end the AIDS epidemic by 2030, focusing on increasing access to treatment and reducing new VIH infections worldwide.

2017

Launch of the U=U Campaign

The U=U (Undetectable = Untransmittable) campaign was launched in 2017, emphasizing that individuals with an undetectable viral load cannot transmit VIH to sexual partners, reducing stigma and promoting treatment adherence.

2020

COVID-19 Pandemic Impact on VIH Services

The COVID-19 pandemic in 2020 disrupted VIH services globally, highlighting the need for resilient healthcare systems and innovative approaches to maintain treatment and prevention efforts during crises.

2021

Advancements in Long-Acting Injectable Treatments for VIH

In 2021, long-acting injectable treatments for VIH were approved, offering an alternative to daily oral antiretroviral therapy, improving adherence and quality of life for many patients.

2022

Global Commitment to End Stigma Surrounding VIH/AIDS

In 2022, global health leaders committed to ending stigma and discrimination associated with VIH/AIDS, recognizing that social barriers significantly hindered prevention and treatment efforts.

2023

Innovations in VIH Vaccine Research Continue

As of 2023, ongoing research and clinical trials for a viable VIH vaccine continue, with promising results indicating potential breakthroughs in preventing the virus and ultimately ending the epidemic.

2024

New Strategies for VIH Prevention and Treatment Announced

In 2024, health organizations announced new strategies focusing on integrated care models for VIH prevention and treatment, aiming to enhance accessibility and effectiveness of services for affected populations worldwide.